Evidence map›Paper›PMID 26936395›Full record

ArticleNeoplasia (New York, N.Y.)2016

Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis.

Stav Sapoznik, Keren Bahar-Shany, Hadar Brand, Yishay Pinto, Orshay Gabay, Efrat Glick-Saar, Chen Dor, Oranit Zadok, Iris Barshack, Adi Zundelevich and 10 more

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Activation-induced cytidine deaminase expression in colorectal cancer.International journal of clinical and experimental pathology · 2019
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Stav SapoznikSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Keren Bahar-ShanySheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Hadar BrandSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, 69978, Israel.
Yishay PintoThe Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan, 52900, Israel.
Orshay GabayThe Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan, 52900, Israel.
Efrat Glick-SaarSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Chen DorSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Oranit ZadokDepartment of Pathology, Chaim Sheba Medical Center, Ramat-Gan 52621, Israel.
Iris BarshackDepartment of Pathology, Chaim Sheba Medical Center, Ramat-Gan 52621, Israel.
Adi ZundelevichSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Einav Nili Gal-YamSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel; The Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Yuval YungIVF Unit and Reproduction Lab, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, 52621, Israel.
Ariel HourvitzIVF Unit and Reproduction Lab, Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, 52621, Israel.
Jacob KorachDepartment of Gynecologic Oncology, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Mario BeinerDepartment of Gynecologic Oncology, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Jasmine JacobSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Erez Y LevanonThe Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan, 52900, Israel.
Michal BarakThe Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat-Gan, 52900, Israel.
Sarit Aviel-RonenDepartment of Pathology, Chaim Sheba Medical Center, Ramat-Gan 52621, Israel; The Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel.
Keren LevanonSheba Cancer Research Center, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Ramat Aviv, 69978, Israel; The Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Ramat Gan, 52621, Israel. Electronic address: Keren.Levanon@Sheba.health.gov.il.
Sheba Medical Center · ILBar-Ilan University · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the notion that ovarian carcinoma results from ovulation-induced inflammation of the fallopian tube epithelial cells (FTECs) has gained evidence. However, the mechanistic pathway for this process has not been revealed yet. In the current study, we propose the mutator protein activation-induced cytidine deaminase (AID) as a link between ovulation-induced inflammation in FTECs and genotoxic damage leading to ovarian carcinogenesis. We show that AID, previously shown to be functional only in B lymphocytes, is expressed in FTECs under physiological conditions, and is induced in vitro upon ovulatory-like stimulation and in vivo in carcinoma-associated FTECs. We also report that AID activity results in epigenetic, genetic and genomic damage in FTECs. Overall, our data provides new insights into the etiology of ovarian carcinogenesis and may set the ground for innovative approaches aimed at prevention and early detection.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)B-LymphocytesCarcinogenesisCytidine DeaminaseDNA DamageEpithelial CellsFallopian TubesFemaleGene Expression Regulation, NeoplasticHumansInflammationOvarian NeoplasmsOvulationAICDA (Activation-Induced Cytidine Deaminase)Cytidine Deaminase

Identifiers

PMID26936395
PMCPMC5005261
OpenAlexW2277113473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.